Impact of Methicillin Resistance on Outcomes of Staphylococcus aureus Bacteremia at a U.S. Center, 2023–2024

Joseph B Ladines-Lim, Aidan Nemiroff, Leigh Cressman, Michael Z David · 2026

Read Impact of Methicillin Resistance on Outcomes of Staphylococcus aureus Bacteremia at a U.S. Center, 2023–2024 by Joseph B Ladines-Lim, Aidan Nemiroff, Leigh Cressman, Michael Z David (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13263529.txt.

Description

Joseph Ladines-Lim and colleagues ask whether drug-resistant staph blood infections still kill more readily than susceptible ones. Three hundred twenty-nine adults with a first Staphylococcus aureus bloodstream infection at two US hospitals anchor their 2026 cohort. About two in five carried the resistant MRSA form.

MRSA patients skewed younger, leaner, and more often injected drugs, with more skin sources but lower initial severity. After adjusting for those differences, resistance predicted nothing worse: not death or hospice, not intensive care, not spreading complications or recurrence. Matched analyses agreed. Modern MRSA, they conclude, differs from MSSA in who it strikes, not in how deadly it proves.

Catalog record

CREATORJoseph B Ladines-Lim, Aidan Nemiroff, Leigh Cressman, Michael Z David
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE36 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13263529

Browse the full library · About the Tower of Babel